Connelly Robert has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 73600 shares of Elicio Therapeutics, Inc. ($ELTX) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Elicio Therapeutics, Inc. | $ELTX | Connelly Robert | CEO, President and Director | A | Common Stock | 73600 | $0.00 | 120,570.0000 | 17,489,516 | 156.70% | 0.42% |
| Feb. 2, 2026 | Elicio Therapeutics, Inc. | $ELTX | Connelly Robert | CEO, President and Director | A | Stock Option (Right to Buy) | 147200 | $0.00 | 147,200.0000 | 17,489,516 | 9999.99% | 0.84% |
| Feb. 3, 2025 | Elicio Therapeutics, Inc. | $ELTX | Connelly Robert | CEO, President and Director | A | Stock Option (Right to Buy) | 121600 | $0.00 | 121,600.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Elicio Therapeutics, Inc. | $ELTX | Connelly Robert | CEO, President and Director | A | Stock Option (Right to Buy) | 91600 | $0.00 | 91,600.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Elicio Therapeutics, Inc. | $ELTX | Connelly Robert | CEO, President and Director | A | Stock Option (right to buy) | 225137 | $0.00 | 225,137.0000 | 0 | 9999.99% | 0.00% |